Literature DB >> 21887553

Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis.

Chibo Liu1, Liu Liu.   

Abstract

Common genetic variations in the leptin (LEP), leptin receptor (LEPR), and paraoxonase 1 (PON1) genes have been considered to be implicated in the development of breast cancer. However, the results were inconsistent. In this study, a meta-analysis was performed to assess the associations of five polymorphisms, including LEP G2548A, LEPR Q223R, LEPR Lys109Arg, PON1 L55M, and PON1 Q192R polymorphisms, with breast cancer risk. Published literature from PubMed, ISI Web of Science, Embase databases, CNKI, and Wanfang Data were retrieved. All studies evaluating the association between LEP G2548A, LEPR Q223R, LEPR Lys109Arg, PON1 L55M, or PON1 Q192R polymorphism and breast cancer risk were included. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects model. Three studies (2,003 cases and 1,967 controls) for LEP G2548A polymorphism, nine studies (4,627 cases and 5,476 controls) for LEPR Q223R polymorphism, five studies (2,759 cases and 2,573 controls) for LEPR Lys109Arg polymorphism, four studies (1,517 cases and 1,379 controls) for PON1 L55M polymorphism, and five studies (1,575 cases and 2,283 controls) for PON1 Q192R polymorphism were included in the meta-analysis. Overall, the results showed null significant association between LEP G2548A, LEPR Q223R, LEPR Lys109Arg, or PON1 Q192R polymorphism and breast cancer risk; however, PON1 L55M was significantly associated with breast cancer risk overall (MM vs. LL: OR = 2.16; 95% CI, 1.76-2.66). For LEPR Q223R polymorphism, further subgroup analysis suggested that the association was only statistically significant in East Asians (OR = 0.50; 95% CI, 0.36-0.70) but not in Caucasians (OR = 1.06; 95% CI, 0.77-1.45) or Africans (OR = 1.30; 95% CI, 0.83-2.03). The present meta-analysis suggested that LEPR Q223R polymorphism might be implicated in the development of breast cancer in East Asians; PON1 L55M might increase breast cancer risk. However, given the limited sample size, the findings warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887553     DOI: 10.1007/s13277-011-0227-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

2.  Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.

Authors:  M I Mackness; S Arrol; B Mackness; P N Durrington
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

3.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.

Authors:  Michelle Harvie; Anthony Howell; Robert A Vierkant; Nagi Kumar; James R Cerhan; Linda E Kelemen; Aaron R Folsom; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

Review 6.  Molecular mechanisms of leptin and adiponectin in breast cancer.

Authors:  Thierry Jardé; Stéphane Perrier; Marie-Paule Vasson; Florence Caldefie-Chézet
Journal:  Eur J Cancer       Date:  2011-01       Impact factor: 9.162

7.  Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.

Authors:  Marianna Terrasi; Elena Fiorio; Anna Mercanti; Mariusz Koda; Camilo A Moncada; Stanislaw Sulkowski; Salim Merali; Antonio Russo; Eva Surmacz
Journal:  Int J Cancer       Date:  2009-09-01       Impact factor: 7.396

8.  Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease.

Authors:  Lisa Gallicchio; Meghan A McSorley; Craig J Newschaffer; Han-Yao Huang; Lucy W Thuita; Sandra C Hoffman; Kathy J Helzlsouer
Journal:  Cancer Detect Prev       Date:  2007-04-10

9.  No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk.

Authors:  Lauren R Teras; Michael Goodman; Alpa V Patel; Mark Bouzyk; Weining Tang; W Ryan Diver; Heather Spencer Feigelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-01       Impact factor: 4.254

10.  Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.

Authors:  Michael N Okobia; Clareann H Bunker; Seymour J Garte; Joseph M Zmuda; Emmanuel R Ezeome; Stanley N Anyanwu; Emmanuel E Uche; Lewis H Kuller; Robert E Ferrell; Emanuela Taioli
Journal:  BMC Cancer       Date:  2008-11-18       Impact factor: 4.430

View more
  18 in total

1.  Correlation between PON1 gene polymorphisms and breast cancer risk: a Meta-analysis.

Authors:  Yayuan Wen; Zemin Huang; Xiaohua Zhang; Bo Gao; Yujun He
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study.

Authors:  Martha L Slattery; Abbie Lundgreen; Lisa Hines; Roger K Wolff; Gabriella Torres-Mejia; Kathy N Baumgartner; Esther M John
Journal:  Cancer Epidemiol       Date:  2015-09-26       Impact factor: 2.984

3.  Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.

Authors:  Daniel S Kim; Amber A Burt; David R Crosslin; Peggy D Robertson; Jane E Ranchalis; Edward J Boyko; Deborah A Nickerson; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

4.  Dietary cholesterol increases paraoxonase 1 enzyme activity.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Karen S Nakayama; Ella R Jarvik; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-08-15       Impact factor: 5.922

5.  Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.

Authors:  Valeria Simone; Morena D'Avenia; Antonella Argentiero; Claudia Felici; Francesca Maria Rizzo; Giovanni De Pergola; Franco Silvestris
Journal:  Oncologist       Date:  2016-02-10

6.  Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.

Authors:  Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

7.  The Association between Leptin Level and Breast Cancer: A Meta-Analysis.

Authors:  Jingping Niu; Le Jiang; Weiheng Guo; Liang Shao; Yi Liu; Liqin Wang
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

8.  Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipids       Date:  2012-05-22

9.  Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer.

Authors:  Marjory Alana Marcello; Antonio Ramos Calixto; Jacqueline Fatima Martins de Almeida; Mariana Bonjiorno Martins; Lucas Leite Cunha; Camila Ayume Amano Cavalari; Elba C S Etchebehere; Ligia Vera Montalli da Assumpção; Bruno Geloneze; Andre Lopes Carvalho; Laura Sterian Ward
Journal:  Int J Endocrinol       Date:  2015-02-25       Impact factor: 3.257

10.  CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.

Authors:  Chibo Liu; Haibao Wang; Chunqin Pan; Jianmin Shen; Yong Liang
Journal:  Tumour Biol       Date:  2012-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.